Prospective Study Comparing Clinicians' and Cancer Patients' Estimates of Risk of Relapse and Toxicity with Adjuvant Chemotherapy. (14th September 2021)

• Record Type: Journal Article
• Authors: Calderon, Caterina; Jiménez-Fonseca, Paula; Hernández, Raquel; Muñoz, María del Mar; Martínez de Castro, Eva; Higuera, Oliver; Ghanem, Ismael; Castelo, Beatriz; Rogado, Jacobo; Carmona-Bayonas, Alberto
• Is Part Of: Cancer investigation. Volume 39:Number 8(2021)
• Page Start: 589
• Page End: 596
• Publication Date: 2021-09-14
• Subjects: Chemotherapy -- prognosis and response predictions -- quality of life -- supportive care and symptom control -- treatment; Cancer -- Periodicals; Oncology -- Periodicals; Medical Oncology -- Periodicals; Neoplasms -- Periodicals; 616.994
• DOI: 10.1080/07357907.2021.1948561
• Languages: English
• ISSNs: 0735-7907

Abstract

Abstract: The aim of this study was to compare physicians' and patients' estimates of risk of relapse and toxicity. A prospective, cross-sectional, multicenter study including 735 patients with cancer and 29 oncologists. Physicians' appraisals of risk of relapse with and without chemotherapy (27.5% and 43.1%) and risk of severe toxicity (12.2%) were more realistic than those of patients (34.6%, 78.5%, and 57.4%, respectively). The greater the risk of recurrence and risk of toxicity estimated, the less physicians expressed satisfaction with SDM. Estimations of risk of relapse and toxicity are important in diagnostic and therapeutic decision-making and can help patients face their situation.